Navigation Links
Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings

News of interest for post menopausal women with breast cancer positive to hormone receptors and HER2 -addition of both Herceptin (trastuzumab) from Roche// and Arimidex (anastrozole) from AstraZeneca to their treatment improves the length of progression free time by 4.8 months.

A Phase III clinical trial sponsored by Roche showed that Arimidex alone inhibited the progression by just 2.4 months after which the cancer continued to progress.

Hormone sensitive breast cancer is seen in 66% of postmenopausal breast cancer and 25% are HER2 positive. The cancer is therefore a very aggressive form and the chances of relapse are higher.

Roche had already announced in May that the Herceptin-Arimidex combination was proving to be particularly effective. It announced the full findings on Monday in Istanbul at the European Society for Medical Oncology Congress.

Dr. Bella Kaufman, from Israel's Chaim Sheba Medical Centre, who had led the trial, said the findings were extremely positive, as double progression free survival is rare in breast cancer trials.

The trial also showed that overall survival was also prolonged to an average of 28.5 months. However this is not considered statistically significant since patients on Arimidex alone have their survival prolonged to 23.9 months.

Additional data showed that introducing anastrozole instead of Tamoxifen in early hormone sensitive breast cancer among postmenopausal women increased their chances of avoiding disease recurrence.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Drug Combo Works Better for children with ADHD, Tics
2. Scanning Combo Helps Detect Lung Cancer
3. Relief From Asthma With New Combo Therapy
4. Calcium-Vitamin D Combo For Reduced Fracture Risk
5. Drug Combo Improves Performance Of Multiple Sclerosis Drug
6. Alcohol-illusion: Alcohol and Energy Drinks Combo, Maintains Sobriety?
7. HER-2 Positive Breast Cancer Patients May Benefit With a Combo Drug Strategy
8. The Combo Treatment Is Effective to Treat Type 1 Diabetes in Mice
9. Doomed Duo: Obesity and Type 2 Diabetes Combo, Can Nip Life in the Bud
10. Fuzeon and MK-0518 Combo Holds Promise For HIV
11. Germ - Chemo Combo Fights Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... , ... August 16, 2017 , ... Fusion Flix Inc., ... original programming over four countries and millions of viewers in a partnership with the ... or buy On-Demand and fully available on Blu Ray disc in 2018. Proceeds will ...
(Date:8/16/2017)... Utah (PRWEB) , ... August 16, 2017 , ... Connexion ... the Inc 5000 list for the fourth consecutive year. With 197% revenue ... 2017 list of the nation’s fastest growing companies. , Previous honors include ...
(Date:8/16/2017)... Ridge, NJ (PRWEB) , ... August 16, 2017 ... ... Hills is offering an opportunity for men and women to train as ... their families dealing with life-limiting illness. For over 30 years, the agency has ...
(Date:8/16/2017)... ... 16, 2017 , ... As part of the Arrow Wellness ... their local business community, Riverfront Fitness is the first of many recipients vying ... integral part of treating those suffering from sudden cardiac arrest in the few ...
(Date:8/16/2017)... ... , ... With low back pain afflicting 8 of 10 Americans at some point in their ... back pain. But this equally vexing condition stems from a variety of causes that can ... PhD , founder and president of Atlantic Spine Center. , Nestled between your neck ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... HOUSTON , Aug. 15, 2017   Mostyn Law ... in Houston, Texas . The Mostyn Law ... the past 2 years. That is why Mostyn Law ... Texas to show its appreciation. Blood supplies ... to fall 5% short of hospital needs in August. That is ...
(Date:8/15/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO), is now ... residents. Naloxone is available without a ... pharmacy, G-3320 Beecher Road. ... Administration, is intended to block or reverse the effects ... of consciousness. The medication is often carried by first ...
(Date:8/15/2017)... HIGH POINT, N.C. , Aug. 15, 2017  Axium Pharmaceuticals Inc., ... epilepsy is rumored to be in the beginning stages of an IPO. ... billion annually on epilepsy medications with the average cost of a prescription ... ... Another staggering figure is ...
Breaking Medicine Technology: